CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

Abstract

Genome editing tools such as the clustered regularly interspaced short palindromic repeat (CRISPR)-associated system (Cas) have been widely used to modify genes in model systems including animal zygotes and human cells, and hold tremendous promise for both basic research and clinical applications. To date, a serious knowledge gap remains in our understanding of DNA repair mechanisms in human early embryos, and in the efficiency and potential off-target effects of using technologies such as CRISPR/Cas9 in human pre-implantation embryos. In this report, we used tripronuclear (3PN) zygotes to further investigate CRISPR/Cas9-mediated gene editing in human cells. We found that CRISPR/Cas9 could effectively cleave the endogenous β-globin gene (HBB). However, the efficiency of homologous recombination directed repair (HDR) of HBB was low and the edited embryos were mosaic. Off-target cleavage was also apparent in these 3PN zygotes as revealed by the T7E1 assay and whole-exome sequencing. Furthermore, the endogenous delta-globin gene (HBD), which is homologous to HBB, competed with exogenous donor oligos to act as the repair template, leading to untoward mutations. Our data also indicated that repair of the HBB locus in these embryos occurred preferentially through the non-crossover HDR pathway. Taken together, our work highlights the pressing need to further improve the fidelity and specificity of the CRISPR/Cas9 platform, a prerequisite for any clinical applications of CRSIPR/Cas9-mediated editing.

Cited by papers we hold 14

• Human embryonic genome activation initiates at the one-cell stage · 2022
  No notice
• Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective · 2020
  No notice
• CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy · 2020
  No notice
• Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia · 2020
  No notice
• The promise and challenge of therapeutic genome editing · 2020
  No notice
• Gene editing and CRISPR in the clinic: current and future perspectives · 2020
  No notice
• Stammzellforschung · 2018
  Not checked
• Digital Twins in Health Care: Ethical Implications of an Emerging Engineering Paradigm · 2018
  No notice
• Directed evolution of CRISPR-Cas9 to increase its specificity · 2018
  No notice
• Genome Editing in Neurosciences · 2017
  Not checked
• Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus · 2017
  No notice
• Correction of β-thalassemia mutant by base editor in human embryos · 2017
  No notice
• CRISPR/Cas9 Immune System as a Tool for Genome Engineering · 2016
  No notice
• What is CRISPR/Cas9? · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.